insights_auto
Kwa nini ALNOV imepungua kwa 3.91%?
Fahamu zaidichevron_right
ALNOV:EPA
Novacyt SA
€ 0.42
arrow_downward
-3.91%(-0.017) Siku 1
3 Nov, 17:35:24 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALNOV...
Fungua
€ 0.43
Juu
€ 0.43
Chini
€ 0.41
Mtaji wa soko
32.69M
Wastani wa kiasi cha mauzo
elfu 197.75
Kiasi cha mauzo ya hisa
elfu 170.68
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.38
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Fungua
€ 0.43
Juu
€ 0.43
Chini
€ 0.41
Mtaji wa soko
32.69M
Wastani wa kiasi cha mauzo
elfu 197.75
Kiasi cha mauzo ya hisa
elfu 170.68
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.38
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
saa 1 iliyopita
There's a 99% Chance That Democrats Retake the House, and History Says This Shift Will Have a Huge Impact on Stocks
Quantisnow
·
dakika 29 zilizopita
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bloomberg.com
·
dakika 41 zilizopita
Stock Futures Rise on AI Recovery as US Votes: Markets Wrap
CNBC
·
saa 11 zilizopita
The most bearish post-midterm scenario that could take the S&P 500 down 10%
Wasifu
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Kuhusu Novacyt SA
Afisa Mkuu Mtendaji (CEO)David Allmond
Wafanyakazi228
Lilianzishwa3 Jul 2006
Makao makuu-
Sekta-
Industry-
Tovutinovacyt.com